CClinicalTrials.gg
RecruitingNCT06920680Updated Dec 22, 2025

ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos

An observational study in Colorectal Cancer, Colonoscopy and Polypectomy, sponsored by Wuerzburg University Hospital. Recruiting at 2 sites in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by Wuerzburg University Hospital · Observational

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,834
Ages
18 Years and older
Sex
All
01

Study summary

With the participants help, the investigators aim to track treatment methods, treatment outcomes, and adverse events, as well as document the treatment strategies used during endoscopic colorectal cancer prevention and treatment. This will allow us to verify if the results from targeted clinical studies and current scientific knowledge are also reflected in the real world. Additionally, the investigators want to use the collected videos and findings to support the training of doctors. During each examination, doctors must be able to accurately assess the inside of the body. Teaching materials for this purpose are scarcely available, often outdated (especially images), and usually show obvious cases. The investigators aim to provide doctors with the opportunity to learn outside of real patient examinations and benefit from the experiences of others.

Furthermore, the investigators want to make the findings and video data accessible to the scientific community. Since scientific studies rarely publish raw data for this purpose, there is currently no large and constantly updated database of findings, images, and videos. If a study requires such data, new data must be collected with great organizational and financial effort. As a result, different studies are only partially comparable, and their significance is reduced.

By publishing the data, a valuable information source for medical professionals in training, continuing education, and advanced training is created. Researchers also benefit from this data: New technologies, such as image analysis software, can be tested and compared on a consistent basis. Therefore, participation in this study makes a valuable contribution to the foundation of good medical care: education, research, and quality assurance.

Primary Study Goal:

The study aims to evaluate the effectiveness and safety of different endoscopic resection techniques. Effectiveness is defined as achieving a complete removal of the lesion (R0 resection) or having a clear follow-up in more than 90% of cases. Safety is defined as having less than 3% of cases result in complications like perforation, uncontrollable bleeding, or the need for unplanned follow-up due to issues like interval bleeding or perforation. The target diagnostic accuracy is 95%.

Secondary Study Goals:

  1. Ensure that in 90% of cases, the recommended follow-up interval aligns with current national guidelines based on the number, size, and histopathology of polyps.
  2. Achieve successful retrieval of polyps in more than 95% of cases.
  3. Document minor bleedings, defined as continuous bleeding for over 30 seconds that requires clipping.

Tertiary Study Goal:

Develop software that can identify and mask sensitive information (such as names, birth dates, examination dates, and video sections outside the human body) in videos from 1,000 examinations, or flag them for manual review. Similarly, the software should identify and remove sensitive text information in the reports, such as names, birth dates, case numbers, examiners, and phone numbers, or mark the text for manual review.

02

Conditions studied

  • Colorectal Cancer
  • Colonoscopy
  • Polypectomy

Keywords

  • colorectal cancer
  • colonoscopy
  • standardized documentation
  • interventional endoscopy
03

In context

Colorectal Neoplasms

5,600 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 1,834 is above the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Wuerzburg University Hospital is the lead sponsor of 96 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with planned diagnostic or therapeutic colonoscopy.

Inclusion criteria

  • Indication for diagnostic or therapeutic colonoscopy

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,834 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Colonoscopy

    All patients recruited in a study center are included.

06

What researchers measure

Primary outcomes

  1. R0 Resection Rate by Removal Method (lesion size >= 20 mm)

    Rate of histologically complete resection for removed pre-cancerous and cancerous lesions \>= 20 mm.

    Time frame: through study completion, an average of 1 year

  2. Inconspicious follow-up by method of Removal (lesion >= 20 mm)

    Rate of macroscopically endoscopic follow-up examinations within 1 year if performed

    Time frame: through study completion, an average of 1 year

  3. Major Complication Rate (lesion size >= 20 mm)

    Rate of examination related major complications defined as endoscopically uncontrollable bleedings or perforations.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Intervention time by method of removal (>= 20 mm)

    Time required from discovery of a polyp to completed treatment including handling of immediate complications.

    Time frame: through study completion, an average of 1 year

  2. Rate of unforeseen re-examination within 3 months after polypectomie (lesions >= 20 mm)

    Rate of unforeseen re-examination within 3 months after polypectomie (lesions \>= 20 mm)

    Time frame: through study completion, an average of 1 year

07

Study locations

2 of 2 sites recruiting
  • Robert Bosch Krankenhaus
    Stuttgart, Baden-Wurttemberg 70376, Germany
    • Martin Schich, Dr. med · Contact · martin.schich@rbk.de · +49 711 8101-0
    • Martin Schich, Dr. med · Principal investigator
    Recruiting
  • University Hospital Würzburg
    Würzburg, Bavaria 97080, Germany
    • Thomas J. Lux, Dr. med. M. Sc. · Contact · lux_t1@ukw.de · +49931-201-40247
    • Yvonne Josef · Contact · josef_y@ukw.de · +49931-201-40255
    • Thomas J. Lux, Dr. med. M. Sc. · Principal investigator
    Recruiting
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 10, 2024
  • Informed consent form · May 21, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Anonymized images from endoscopy examination videos may be published on an research / educational platform.

Supporting information: Study protocol, Icf, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06920680
Lead sponsor
Wuerzburg University Hospital
Collaborators
Robert Bosch Medical Center, Krankenhaus Barmherzige Brüder, Regensburg, Universitätsklinikum Hamburg-Eppendorf, Klinikum Ludwigsburg
Responsible party
Sponsor
First posted
Apr 10, 2025
Start date
Oct 1, 2024
Primary completion
Oct 2026 (estimated)
Completion
Oct 2027 (estimated)
Last update
Dec 22, 2025

Study contacts

Thomas J. Lux, Dr. med. M. Sc.
Contact
lux_t1@ukw.de
+49 931 201 40247
Yvonne Josef
Contact
josef_y@ukw.de
+49 931 201 40255
Alexander Meining, Prof.
study chair · Wuerzburg University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion